These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 31491399)

  • 1. Enhancing the copy number of Ldrab6 gene in Leishmania donovani parasites mediates drug resistance through drug-thiol conjugate dependent multidrug resistance protein A (MRPA).
    Chauhan IS; Rao GS; Singh N
    Acta Trop; 2019 Nov; 199():105158. PubMed ID: 31491399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiparasitic dibenzalacetone inhibits the GTPase activity of Rab6 protein of Leishmania donovani (LdRab6), a potential target for its antileishmanial effect.
    Chauhan IS; Marwa S; Rao GS; Singh N
    Parasitol Res; 2020 Sep; 119(9):2991-3003. PubMed ID: 32748038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression profiling of dibenzalacetone (DBA) treated intracellular amastigotes of Leishmania donovani.
    Singh N; Chauhan IS
    Exp Parasitol; 2018 Oct; 193():5-19. PubMed ID: 30125570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprevention of Leishmaniasis: In-vitro antiparasitic activity of dibenzalacetone, a synthetic curcumin analog leads to apoptotic cell death in Leishmania donovani.
    Chauhan IS; Rao GS; Shankar J; Chauhan LKS; Kapadia GJ; Singh N
    Parasitol Int; 2018 Oct; 67(5):627-636. PubMed ID: 29913255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India.
    Singh N; Chatterjee M; Sundar S
    Parasit Vectors; 2014 Dec; 7():596. PubMed ID: 25515494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent.
    Dumetz F; Cuypers B; Imamura H; Zander D; D'Haenens E; Maes I; Domagalska MA; Clos J; Dujardin JC; De Muylder G
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionality of drug efflux pumps in antimonial resistant Leishmania donovani field isolates.
    Mandal G; Sarkar A; Saha P; Singh N; Sundar S; Chatterjee M
    Indian J Biochem Biophys; 2009 Feb; 46(1):86-92. PubMed ID: 19374259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ABC transporter MRPA, gamma-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani.
    Mukherjee A; Padmanabhan PK; Singh S; Roy G; Girard I; Chatterjee M; Ouellette M; Madhubala R
    J Antimicrob Chemother; 2007 Feb; 59(2):204-11. PubMed ID: 17213267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and Transcriptomic Analysis for Identification of Genes and Interlinked Pathways Mediating Artemisinin Resistance in
    Ghosh S; Verma A; Kumar V; Pradhan D; Selvapandiyan A; Salotra P; Singh R
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33213096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mitochondrial HSP70 (HSPA9B) is linked to miltefosine resistance and stress response in Leishmania donovani.
    Vacchina P; Norris-Mullins B; Carlson ES; Morales MA
    Parasit Vectors; 2016 Dec; 9(1):621. PubMed ID: 27906059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs.
    Rastrojo A; García-Hernández R; Vargas P; Camacho E; Corvo L; Imamura H; Dujardin JC; Castanys S; Aguado B; Gamarro F; Requena JM
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):246-264. PubMed ID: 29689531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of natural antimony resistance in Leishmania donovani isolates.
    Mittal MK; Rai S; Ashutosh ; Ravinder ; Gupta S; Sundar S; Goyal N
    Am J Trop Med Hyg; 2007 Apr; 76(4):681-8. PubMed ID: 17426170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the proliferating cell nuclear antigen of Leishmania donovani clinical isolates and its association with antimony resistance.
    Tandon R; Chandra S; Baharia RK; Das S; Misra P; Kumar A; Siddiqi MI; Sundar S; Dube A
    Antimicrob Agents Chemother; 2014 Jun; 58(6):2997-3007. PubMed ID: 24614385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).
    Seifert K; Matu S; Javier Pérez-Victoria F; Castanys S; Gamarro F; Croft SL
    Int J Antimicrob Agents; 2003 Oct; 22(4):380-7. PubMed ID: 14522101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elucidation of cellular mechanisms involved in experimental paromomycin resistance in Leishmania donovani.
    Bhandari V; Sundar S; Dujardin JC; Salotra P
    Antimicrob Agents Chemother; 2014 May; 58(5):2580-5. PubMed ID: 24550335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani.
    Purkait B; Singh R; Wasnik K; Das S; Kumar A; Paine M; Dikhit M; Singh D; Sardar AH; Ghosh AK; Das P
    J Antimicrob Chemother; 2015 May; 70(5):1343-56. PubMed ID: 25667407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative genomic, proteomic and phenotypic studies of Leishmania donovani strains revealed genetic features associated with virulence and antimony-resistance.
    Zheng Z; Chen J; Ma G; Satoskar AR; Li J
    Parasit Vectors; 2020 Oct; 13(1):510. PubMed ID: 33046138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the interplay between cysteine synthase and thiol cascade proteins in modulating Amphotericin B resistance and survival of Leishmania donovani under oxidative stress.
    Singh K; Ali V; Pratap Singh K; Gupta P; Suman SS; Ghosh AK; Bimal S; Pandey K; Das P
    Redox Biol; 2017 Aug; 12():350-366. PubMed ID: 28288415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
    Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.
    Jaiswal AK; Rao KB; Kushwaha P; Rawat K; Modukuri RK; Khare P; Joshi S; Mishra S; Rai A; Sashidhara KV; Dube A
    Int J Antimicrob Agents; 2016 Dec; 48(6):695-702. PubMed ID: 27876275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.